Episode 7: Giovanni Amabile, PhD, CEO of Enthera, Developing first-in-class biologics for type 1 diabetes

episode

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

BravoAndy and Bronwyn’s Fanny (Headlines) 1h 0m · 23 Sep 2026 · Two Ts In A Pod with Teddi Mellencamp and Tamra Judge

US diesel dilemma 6 min · 23 Sep 2026 · Wall Street Breakfast

The Great Autumn International Break of 2026™ 50 min · 23 Sep 2026 · Football Ramble

Beating Breast Cancer with Alison Haislip 1h 5m · 23 Sep 2026 · The Jordan Syatt Podcast

1599 - Zac Is Into Trans Women & Prostate Play 1h 0m · 23 Sep 2026 · Strictly Anonymous Confessions

FOMO, Meme Stocks and Robinhood Chain | Andy8052 & Eric Conner 56 min · 23 Sep 2026 · Bankless

Report any issue

Source

Recorded23 Aug 2020

Publisherfeed.podbean.com ↗

Handlerec:2095181

Show notes

In this episode, Giovanni Amabile joins Monica Westley to discuss the future of Enthera. Enthera is a biotech company building a pipeline of first-in-class biologics for several autoimmune conditions, with a focus in type 1 diabetes and inflammatory bowel disease.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related